Consistent with the reported oncogenic role of HOXD9 in other cancers, our study suggested that knockdown of HOXD9 induced proliferative suppression, cell cycle arrest, apoptosis, migratory suppression and invasive repression in two human NSCLC cells. Here, HOXD9 is linked to cancer.